Glycominds
Biotechnology Research • 
Simi Valley, California, United States • 1-10 Employees
Company overview
| Headquarters | 4685 Runway St., STE J, Simi Valley, California 93063, US |
| Phone number | +18054268115 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Chron'S Disease Diagnostics, Inflammatory Bowel Disease (Ibs) Diagnostics, Ulcerative Colitis Diagnostics |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
Key Contact at Glycominds
Stuart Ringold
Director of Operations | North America
About Glycominds
Glycominds, a commercial stage diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease biomarkers with a distinctive focus on the Inflammatory Bowel Disease (IBD).
Glycominds revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Glycominds has never raised funding before.
Glycominds Tech Stack
Discover the technologies and tools that power Glycominds's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Performance
Netherlands
Italy
Germany
United KingdomFrequently asked questions
4.8
40,000 users
